$18.87
0[0.00%]
At close: Apr 26
$18.87
0[0.00%]
After Hours: 4:00PM EDT
NOV Stock (NYSE:NOV), Analyst Ratings, Price Targets, Predictions
NOV Inc has a consensus price target of $20.82, established from looking at the 62 latest analyst ratings. The last 3 analyst ratings were released from Susquehanna, Piper Sandler, and RBC Capital on April 8, 2024, February 20, 2024, and February 6, 2024. With an average price target of $24 between Susquehanna, Piper Sandler, and RBC Capital, there's an implied 27.19% upside for NOV Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Susquehanna
Piper Sandler
RBC Capital
Stifel
Raymond James
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for NOV
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/08/2024 | NOV | Buy Now | NOV | $18.87 | 37.78% | Susquehanna | Charles Minervino | → $26 | Maintains | Positive | Get Alert |
| 02/20/2024 | NOV | Buy Now | NOV | $18.87 | 16.59% | Piper Sandler | Luke Lemoine | $25 → $22 | Maintains | Neutral | Get Alert |
| 02/06/2024 | NOV | Buy Now | NOV | $18.87 | 27.19% | RBC Capital | Keith Mackey | → $24 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 02/05/2024 | NOV | Buy Now | NOV | $18.87 | 37.78% | Stifel | Stephen Gengaro | $28 → $26 | Maintains | Buy | Get Alert |
| 02/05/2024 | NOV | Buy Now | NOV | $18.87 | 32.49% | Raymond James | James Rollyson | $28 → $25 | Maintains | Outperform | Get Alert |
| 01/16/2024 | NOV | Buy Now | NOV | $18.87 | — | Benchmark | Kurt Hallead | — | Downgrade | Buy → Hold | Get Alert |
| 12/12/2023 | NOV | Buy Now | NOV | $18.87 | 53.68% | TD Cowen | Marc Bianchi | $28 → $29 | Maintains | Outperform | Get Alert |
| 12/08/2023 | NOV | Buy Now | NOV | $18.87 | 32.49% | JP Morgan | Arun Jayaram | → $25 | Upgrade | Neutral → Overweight | Get Alert |
| 10/30/2023 | NOV | Buy Now | NOV | $18.87 | 27.19% | RBC Capital | Keith Mackey | $23 → $24 | Maintains | Sector Perform | Get Alert |
| 10/30/2023 | NOV | Buy Now | NOV | $18.87 | 53.68% | Raymond James | James Rollyson | $28 → $29 | Maintains | Outperform | Get Alert |
| 10/17/2023 | NOV | Buy Now | NOV | $18.87 | 32.49% | Morgan Stanley | Elizabeth Porter | $24 → $25 | Maintains | Overweight | Get Alert |
| 10/03/2023 | NOV | Buy Now | NOV | $18.87 | 11.29% | Wells Fargo | Roger Read | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | NOV | Buy Now | NOV | $18.87 | -4.61% | Goldman Sachs | Neil Mehta | $16 → $18 | Maintains | Sell | Get Alert |
| 08/01/2023 | NOV | Buy Now | NOV | $18.87 | 27.19% | Morgan Stanley | Elizabeth Porter | $22 → $24 | Maintains | Overweight | Get Alert |
| 08/01/2023 | NOV | Buy Now | NOV | $18.87 | 37.78% | Citigroup | Scott Gruber | $21 → $26 | Maintains | Buy | Get Alert |
| 07/31/2023 | NOV | Buy Now | NOV | $18.87 | 5.99% | Piper Sandler | Luke Lemoine | $21 → $20 | Maintains | Neutral | Get Alert |
| 07/31/2023 | NOV | Buy Now | NOV | $18.87 | 27.19% | Morgan Stanley | Elizabeth Porter | $22 → $24 | Maintains | Overweight | Get Alert |
| 07/31/2023 | NOV | Buy Now | NOV | $18.87 | 48.38% | Benchmark | Kurt Hallead | → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2023 | NOV | Buy Now | NOV | $18.87 | 37.78% | Citigroup | Scott Gruber | $21 → $26 | Maintains | Buy | Get Alert |
FAQ
What is the target price for NOV (NOV)?
The latest price target for NOV (NYSE: NOV) was reported by Susquehanna on April 8, 2024. The analyst firm set a price target for $26.00 expecting NOV to rise to within 12 months (a possible 37.78% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NOV (NOV)?
The latest analyst rating for NOV (NYSE: NOV) was provided by Susquehanna, and NOV maintained their positive rating.
When was the last upgrade for NOV (NOV)?
The last upgrade for NOV Inc happened on December 8, 2023 when JP Morgan raised their price target to $25. JP Morgan previously had a neutral for NOV Inc.
When was the last downgrade for NOV (NOV)?
The last downgrade for NOV Inc happened on January 16, 2024 when Benchmark changed their price target from N/A to N/A for NOV Inc.
When is the next analyst rating going to be posted or updated for NOV (NOV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NOV, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NOV was filed on April 8, 2024 so you should expect the next rating to be made available sometime around April 8, 2025.
Is the Analyst Rating NOV (NOV) correct?
While ratings are subjective and will change, the latest NOV (NOV) rating was a maintained with a price target of $0.00 to $26.00. The current price NOV (NOV) is trading at is $18.87, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.